Member Exclusive

Colorimetric study helps identify promising therapeutics for prostate cancer

Researchers at the University of Bath (UK) have developed a test to allow structure-activity relationship studies to be carried out on a key prostate cancer protein, revealing potential inhibitor compounds.

Go to the profile of Benjamin Walden
May 16, 2018

Please sign in or register for FREE

Register to MedChemNet

MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.


No comments yet.